Dr. Lewin is president and CEO of the Cardiovascular Research Foundation, a global enterprise focused on pre-clinical science, human clinical trials and interventional cardiology education.
Dr. Lewin will discuss the costs for medical innovation, regulatory scrutiny and time-to-market disadvantages.
More articles on spine:
Spine surgery for ‘Generation Me’: Will customization lead to better outcomes?
4 spine, neurosurgery practice expansions
Dr. Richard Francis develops patient-to-patient ambassador program
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.